Award recordCONTRACT

BAYER HEALTHCARE PHARMACEUTICALS INC

PIID 36C25019F0071· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $222,838 net obligations· UEI V1EVGCK7XES8· NJ

Description

DECREASE FUNDING REQUIRED. IGF OT IGF RADIUM-223 DICHLORIDE (XOFIGO)

Base award description: IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO)

First action · last action
2018-10-01 · 2020-04-03
Transactions
3
First transaction's obligation
$209,932
Base + all options value (sum of deltas)
$222,838
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25114A0051
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$309,873$0Base award · 2018-10-01 · this action $209,932 · running total $209,932Modification P00001 · 2019-09-11 · this action $99,941 · running total $309,873Modification P00002 · 2020-04-03 · this action -$87,035 · running total $222,838
  • Base2018-10-01+$209,932= $209,932
  • Mod P000012019-09-11+$99,941= $309,873
  • Mod P000022020-04-03-$87,035= $222,838
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-01+$209,932$209,932IGF::OT::IGF RADIUM-223 DICHLORIDE (XOFIGO)
Mod P00001· FUNDING ONLY ACTION2019-09-11+$99,941$309,873ADDITIONAL FUNDING REQUIRED. IGF OT IGF RADIUM-223 DICHLORIDE (XOFIGO)
Mod P00002· FUNDING ONLY ACTION2020-04-03−$87,035$222,838DECREASE FUNDING REQUIRED. IGF OT IGF RADIUM-223 DICHLORIDE (XOFIGO)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V1EVGCK7XES8)

AwardOffice · PSC / listingNet obligationsFY
36C25626N0492256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$386,860FY2026
36C26226F0163262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$181,386FY2026
36C26026F0086260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$80,663FY2026
36C26126N0199261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$101,567FY2026
36C25626N0126256-NETWORK CONTRACT OFFICE 16 (36C256) · 6505 · DRUGS AND BIOLOGICALS$214,783FY2026
36E79725A0028NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025

Other recipients under 6505 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026P0991ASD SPECIALTY HEALTHCARE, LLC250-NETWORK CONTRACT OFFICE 10 (36C250)$43,680FY2026
36C25026F0668COSETTE PHARMACEUTICALS, INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$10,398FY2026
36C25026N0655PROGENICS PHARMACEUTICALS INC250-NETWORK CONTRACT OFFICE 10 (36C250)$721,744FY2026
36C25026N0616AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$37,180FY2026
36C25026D0061AMERICAN NATIONAL RED CROSS, THE250-NETWORK CONTRACT OFFICE 10 (36C250)$0FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25019F0071_3600_VA25114A0051_3600 · retrieved 2026-09-26.